You W, Hu C, Zhao M, Zhang Y, et al. Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma. Gut 2024 Sep 11:gutjnl-2024-333375. doi: 10.1136/gutjnl-2024-333375.
PMID: 39266052